Skip to main content

Table 1 Demographic and surgical variables, mean ± SD

From: The impact of ultrasound-guided bilateral rectus sheath block in patients undergoing cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy — a retrospective study

 

G group (n = 89)

GR group (n = 89)

P value

Age (y)

46.1 ± 8.2

45.3 ± 8.0

0.512

Sex (male/female)

45/44

36/53

0.176

BMI (kg/m2)

24.92 ± 2.40

24.43 ± 1.77

0.123

Medical history

 Diabetes mellitus (n, yes/no)

27/62

25/64

0.742

 Hypertension (n, yes/no)

40/49

48/41

0.230

 Coronary heart disease (n, yes/no)

11/78

8/81

0.466

 ASA grade I/II/III

32/50/7

36/43/10

0.524

 NYHA grade I/II

59/30

50/39

0.166

 Total surgery time (min)

517.58 ± 87.90

522.97 ± 95.73

0.697

 Time to tracheal extubation (min)

49.48 ± 5.07

37.45 ± 3.89

< 0.001

 Remifentanil (mg)

4.21 ± 0.50

2.18 ± 0.20

< 0.001

 Rocuronium (mg)

101.97 ± 10.85

84.26 ± 9.99

< 0.001

 Total fluid volume (ml)

5491.36 ± 587.99

5543.36 ± 541.21

0.541

 Urine volume (ml)

1310.56 ± 161.35

1324.38 ± 153.75

0.559

 Total volume of allogeneic erythrocyte infusion (ml)

319.55 ± 235.82

329.21 ± 243.18

0.788

 Total volume of plasma (ml)

987.64 ± 114.14

973.71 ± 122.99

0.434

  1. ASA American Society of Anesthesiologists; BMI Body mass index (calculated as weight in kilograms divided by height in metres squared); NYHA New York Heart Association; G General anaesthesia; GR Bilateral rectus sheath block combined with general anaesthesia. Before bilateral rectus sheath block (T1), the time of anaesthesia (T2), the time of skin incision (T3), the time of peritoneal thermochemotherapy (T4), and the end of surgery (T5)